SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Directorate Change

5 Mar 2010 07:00

RNS Number : 1295I
Rentokil Initial PLC
05 March 2010
 



5 March 2010

 

 

 

Rentokil Initial to appoint Jeremy Townsend as Chief Financial Officer

 

Rentokil Initial plc (FTSE: RTO) today announces that Jeremy Townsend will be appointed to the Board as a Director and Chief Financial Officer on leaving his current role.

 

Jeremy Townsend, 46, is currently Finance Director at Mitchells & Butlers, a role he has held since February 2008. Jeremy joined Mitchells & Butlers in June 2005 as Deputy Finance Director. He was previously employed by J Sainsbury plc where he held various finance roles including Group Financial Controller, Corporate Finance Director and Strategy Director. Prior to Sainsbury's, he was employed by Ernst & Young, working in audit and corporate finance. Jeremy is a Fellow of the Institute of Chartered Accountants of England and Wales.

 

The date on which he will join the Board will be announced in due course.

 

Rentokil Initial's current CFO, Michael Murray, indicated some time ago that he would be minded to seek a new challenge outside Rentokil Initial if a suitable replacement could be identified. Mr Murray will leave the Board on 31 March 2010.

 

Alan Brown, Chief Executive Officer of Rentokil Initial plc, said: "We are delighted that Jeremy has chosen to join Rentokil Initial. He has highly relevant experience in managing the financial aspects of a business that operates across many sites with many brands. His expertise will be invaluable as we continue to pursue our Operational Excellence agenda.'

 

"On behalf of the Board I would like to wish Michael well for the future and thank him for his contribution during his time with the group."

There is nothing that is required to be disclosed under Listing Rule 9.6.13 in respect of Jeremy Townsend.

Ends

For further information:

Media enquiries:

Malcolm Padley, Corporate Communications Rentokil Initial plc 07788 978199

Kate Holgate, Tom Williams Brunswick Group 020 7404 5959

 

Shareholder/analyst enquiries:

Katharine Rycroft, Investor Relations Rentokil Initial plc 07811 270734

 

About Rentokil Initial

Rentokil Initial is one of the largest business services companies in the world, operating in all the major economies of Europe, North America, Asia Pacific and Africa.

www.rentokil-initial.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUGUPAWUPUGRC
Date   Source Headline
30th Jan 20074:48 pmRNSHolding(s) in Company
25th Jan 200711:52 amRNSAnnual Calendar 2007
15th Jan 20073:00 pmRNSMerger Update
11th Jan 20075:10 pmRNSAcquisition
11th Jan 20071:36 pmRNSHolding(s) in Company
2nd Jan 20078:47 amRNSAcquisition
22nd Dec 20069:23 amRNSAcquisition
21st Dec 20061:01 pmRNSDirector/PDMR Shareholding
20th Dec 20061:18 pmRNSTotal Voting Rights
20th Dec 200611:08 amRNSDirector/PDMR Shareholding
18th Dec 20067:09 amRNSAcquisition
11th Dec 200611:30 amRNSHolding(s) in Company
7th Dec 200610:44 amRNSDirector/PDMR Shareholding
30th Nov 20067:04 amRNSReview Electronic Security
30th Nov 20067:01 amRNSAcquisition
24th Nov 20062:37 pmRNSHolding(s) in Company
24th Nov 20062:36 pmRNSHolding(s) in Company
10th Nov 200612:34 pmRNSClarification - Q3 Update
9th Nov 20065:07 pmRNSHolding(s) in Company
9th Nov 20069:57 amRNSInvestor Day
8th Nov 20067:01 amRNS3rd Quarter Results
3rd Nov 20068:00 amRNSFrance - Regulatory Inquiry
30th Oct 20065:45 pmRNSHolding(s) in Company
25th Oct 20063:34 pmRNSAcquisition
18th Oct 20065:15 pmRNSHolding(s) in Company
10th Oct 20062:33 pmRNSBank Facilities
25th Sep 20063:20 pmRNSReporting Timetable
24th Aug 20067:00 amRNSInterim Results
11th Aug 20062:39 pmRNSHolding(s) in Company
21st Jul 20069:12 amRNSDisposal
14th Jul 20062:34 pmRNSDirector Declaration
5th Jul 200611:37 amRNSAnnual Information Update
3rd Jul 20064:45 pmRNSHolding(s) in Company
30th Jun 20067:03 amRNSAcquisition
12th Jun 20065:12 pmRNSHolding(s) in Company
12th Jun 20068:09 amRNSDisposal
5th Jun 20065:03 pmRNSHolding(s) in Company
1st Jun 20064:59 pmRNSDirector/PDMR Shareholding
22nd May 20065:20 pmRNSHolding(s) in Company
22nd May 20065:18 pmRNSHolding(s) in Company
17th May 20064:40 pmRNSDirectorate Change
16th May 20062:43 pmRNSHolding(s) in Company
4th May 20067:01 amRNSTrading Statement
6th Apr 200610:42 amRNSDirector/PDMR Shareholding
6th Apr 200610:42 amRNSDirector/PDMR Shareholding
31st Mar 200612:36 pmRNSEMTN Programme
10th Mar 20062:14 pmRNSDisposal
10th Mar 20061:23 pmRNSHolding(s) in Company
8th Mar 200612:45 pmRNSPublication of Prospectus
7th Mar 20061:46 pmRNSDisposal

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.